Endoscopic therapy for gastrointestinal angiodysplasia

Ahmad Alhamid; Ziad Aljarad; Abdelkader Chaar; Alyssa Grimshaw; Ibrahem Hanafi

doi:10.1002/14651858.CD014582

Endoscopic therapy for gastrointestinal angiodysplasia

Cochrane Database Syst Rev. 2024 Sep 19;9(9):CD014582. doi: 10.1002/14651858.CD014582.

Authors

Ahmad Alhamid¹, Ziad Aljarad², Abdelkader Chaar³, Alyssa Grimshaw⁴, Ibrahem Hanafi⁵

Affiliations

¹ Department of stem cell biology, Nagasaki University, Graduate school of biomedical sciences, Atomic Bomb Disease Institute, Nagasaki, Japan.
² Department of Internal Medicine, Faculty of Medicine, Aleppo University, Aleppo, Syrian Arab Republic.
³ Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
⁴ Cushing/Whitney Medical Library, Yale University, New Haven, Connecticut, USA.
⁵ Division of Neurology, Department of Internal Medicine, Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic.

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of the different endoscopic management approaches for gastrointestinal angiodysplasia in symptomatic adults.

MeSH terms

Adult
Angiodysplasia* / complications
Angiodysplasia* / surgery
Endoscopy, Gastrointestinal* / methods
Gastrointestinal Hemorrhage* / etiology
Gastrointestinal Hemorrhage* / surgery
Gastrointestinal Hemorrhage* / therapy
Humans
Randomized Controlled Trials as Topic